Table I.
Basic characteristics of HCV/HCV vs. HIV monoinfected patients
| Parameter | HIV mono-infected | HIV/HCV coinfected | P-value | Total |
|---|---|---|---|---|
| Male, n (%) | 262 (71.2) | 247 (74.2) | 0.37 | 509 (72.6) |
| Age at HIV diagnosis, median (IQR) [years] | 34.0 (27.1–43.4) | 28.1 (23.7–34.1) | < 0.001 | 30.9 (25.5–38.3) |
| HIV infection stage at genotyping, n (%)*: | ||||
| A | 122 (38.1) | 136 (45.5) | < 0.001 | 258 (41.7) |
| B | 102 (31.9) | 113 (37.8) | 215 (34.7) | |
| C | 96 (30.0) | 50 (16.7) | 146 (23.6) | |
| Dominant transmission route, n (% of total)*: | ||||
| IDU (intravenous drug use) | 22 (6.8) | 257 (83.7) | < 0.001 | 279 (44.2) |
| MSM (men having sex with men) | 143 (44.0) | 19 (6.2) | 162 (25.6) | |
| HET (heterosexual) | 160 (49.2) | 31 (10.1) | 191 (30.2) | |
| Lymphocyte CD4+ T cell count at care entry, median (IQR) | 250 (70–519) | 283 (116–475) | 0.169 | 277 (93–496) |
| HIV viral load at care entry, mean log copies/ml (SD) | 4.98 (4.31–5.61) | 4.15 (4.72–5.2) | 0.003 | 4.91 (4.21–5.52) |
*
CDC category not available for 82 individuals, transmission route not available for 69 cases.